The steady decline of pharmaceutical sales representative access to physicians is spreading to previously rep-friendly specialties, says the ZS Associates spring 2014 AccessMonitorT report.

The report aggregated sales-call summaries from more than 200 U.S. pharmaceutical sales teams and examined how often approximately 325,000 physicians and other prescribers meet with the pharmaceutical sales reps who visit their offices.

Overall access to physicians has declined by 33 per cent since the first report in 2008. Approximately half (49 per cent) of physicians in the U.S. placed moderate-to-severe restrictions on visits from pharma sales reps in 2014.

via Pharma Rep Access Down 33 Per Cent Since 2008.

Recommended Posts